Florey Institute of Neuroscience and Mental Health

The Florey Institute of Neuroscience and Mental Health, more commonly known as the Florey Institute, is an Australian medical research institute that undertakes clinical and applied research into treatments for brain and mind disorders and the cardiovascular system

A new type of hydrogel could radically transform how we treat Parkinson’s disease

A tiny device that could one day offer an alternative to open brain surgery

Researchers have demonstrated the feasibility of a tiny device that could one day offer an alternative to open brain surgery One of the treatments for managing Parkinson’s Disease is to use deep electrical brain stimulation to relieve debilitating symptoms like muscle stiffness and tremors. But it’s a daunting procedure. Surgeons must cut into the skull

A tiny device that could one day offer an alternative to open brain surgery

New device to get people with paralysis back on their feet

Melbourne medical researchers have created a new minimally invasive brain-machine interface, giving people with spinal cord injuries new hope to walk again with the power of thought. The brain machine interface consists of a stent-based electrode (stentrode), which is implanted within a blood vessel next to the brain, and records the type of neural activity

New device to get people with paralysis back on their feet

The Latest Bing News on:

Florey Institute of Neuroscience and Mental Health Research

Florey Institute of Neuroscience and Mental Health
on August 10, 2021 at 1:14 pm
Early reports suggested an apparent increase in OCD relapse rates and symptom severity during the pandemic. But a year on, we’re learning this may not be the case.
Australian research a hope for Parkinson's
on August 9, 2021 at 11:38 pm
Researchers from the Australian National University, in collaboration with the Florey Institute of Neuroscience and Mental Health, hope to start clinical trials within five years of a 'hydrogel ...
World's first global research institute for psychedelic therapies opens its doors
on August 3, 2021 at 8:56 pm
Florey Institute of Neuroscience and Mental Health, and NICM Health Research Institute (Sydney); as well as Agriculture Victoria Research. The not-for-profit Institute will advance pre-clinical ...
Innovative gel offers new hope to defeat Parkinson's disease
on August 2, 2021 at 5:00 pm
Researchers from The Australian National University (ANU), in collaboration with The Florey Institute of Neuroscience and Mental Health ... Curtin School of Medical Research (JCSMR), said.

The Latest Google Headlines on:

Florey Institute of Neuroscience and Mental Health Research

The Latest Bing News on:

Florey Institute of Neuroscience and Mental Health Discovery

A Developmental and Genetic Classification for Malformations of Cortical Development
on August 18, 2021 at 5:00 pm
Group I: Malformations Secondary to Abnormal Neuronal and Glial Proliferation or Apoptosis This group continues to be separated into three categories: reduced proliferation or accelerated ...
A Developmental and Genetic Classification for Malformations of Cortical Development
on August 16, 2021 at 5:00 pm
Several studies have shown that abnormalities of the neuroependyma (ventricular epithelium) are associated with periventricular nodular heterotopia (Ferland et al., 2009). Group II has, therefore ...
Neuroscience news
on August 5, 2021 at 5:00 pm
Chronic stress is a well-known cause for mental health disorders. New research has moved a step forward in understanding how glucocorticoid hormones ('stress hormones') act upon the brain and what ...
On Donanemab, Plaques Plummet. Off Donanemab, They Stay Away
on August 5, 2021 at 5:00 pm
Lilly originally developed the assay on the Meso Scale Discovery platform, which works like an ELISA. At AAIC, Mintun debuted the assay’s adaptation to the more sensitive Simoa platform. Several ...
Neuroscience news
on August 5, 2021 at 5:00 pm
Riluzole, a drug that has been used for more than 20 years to slow the progression of ALS, commonly known as Lou Gehrig's disease, was shown in a pilot phase 2 study to slow brain metabolic ...